Cargando…

Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson’s disease by inhibiting SP1

Background: This study is conducted to investigate the protective role of elevated microRNA-375 (miR-375) in dopaminergic neurons in Parkinson’s disease through down-regulating transcription factor specificity protein 1 (SP1). Results: The successfully modeled rats with Parkinson’s disease showed ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Li-Jun, Tu, Li, Li, Tian, Yang, Xiu-Lin, Ren, Yi-Pin, Gu, Ran, Zhang, Qian, Yao, Huan, Qu, Xiang, Wang, Qian, Tian, Jin-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977707/ https://www.ncbi.nlm.nih.gov/pubmed/31927536 http://dx.doi.org/10.18632/aging.102649

Ejemplares similares

In situ analysis of acupuncture protecting dopaminergic neurons from lipid peroxidative damage in mice of Parkinson's disease
por: Zuo, Tingting, et al.
Publicado: (2022)

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
por: Tu, Li, et al.
Publicado: (2019)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson’s disease
por: Gao, Qing, et al.
Publicado: (2017)

Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson’s disease mouse model through activating GHS-R1a/D(2)R heterodimers
por: Tang, Ting-ting, et al.
Publicado: (2023)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson’s Disease in Rats
por: He, Dewei, et al.
Publicado: (2018)

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
por: Huh, Eugene, et al.
Publicado: (2019)

Quercetin Protects against MPP(+)/MPTP-Induced Dopaminergic Neuron Death in Parkinson's Disease by Inhibiting Ferroptosis
por: Lin, Zhi-Hao, et al.
Publicado: (2022)

Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
por: Wang, Ronglin, et al.
Publicado: (2018)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease
por: Yao, Yufang, et al.
Publicado: (2023)

MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1
por: Xu, Hui, et al.
Publicado: (2019)

Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis
por: Huang, Zifeng, et al.
Publicado: (2021)

MicroRNA-375 Is Induced during Astrocyte-to-Neuron Reprogramming and Promotes Survival of Reprogrammed Neurons when Overexpressed
por: Chen, Xuanyu, et al.
Publicado: (2023)

Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson’s Disease in Rats
por: Chen, Guangxin, et al.
Publicado: (2017)

Dopaminergic neurons: linking longevity with reproduction?
por: Tian, Xiaolin
Publicado: (2022)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models
por: Alsharif, Ifat, et al.
Publicado: (2020)

Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
por: Que, Rongfang, et al.
Publicado: (2021)

DNA methylation of microRNA-375 in impaired glucose tolerance
por: WANG, XIAOLI, et al.
Publicado: (2014)

UCHL1 regulated by Sp1 ameliorates cochlear hair cell senescence and oxidative damage
por: Li, Lihua, et al.
Publicado: (2023)

Roles of Transcription Factors in the Development and Reprogramming of the Dopaminergic Neurons
por: Tian, Lulu, et al.
Publicado: (2022)

Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease
por: Yan, Jianguo, et al.
Publicado: (2022)

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson's Disease
por: Wang, Yanqin, et al.
Publicado: (2017)

Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models
por: Lu, Tao, et al.
Publicado: (2017)

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis
por: McNeill, Alisdair, et al.
Publicado: (2013)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson’s Disease Models
por: Bi, Mingxia, et al.
Publicado: (2018)

Stress increases MHC-I expression in dopaminergic neurons and induces autoimmune activation in Parkinson's disease
por: Wang, Bao-Yan, et al.
Publicado: (2021)

Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson's Disease
por: Yong, Yuxuan, et al.
Publicado: (2023)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
por: Chung, Young Cheul, et al.
Publicado: (2013)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)

MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson’s Disease
por: Sun, Sifan, et al.
Publicado: (2018)

Exercise Ameliorates Motor Deficits and Improves Dopaminergic Functions in the Rat Hemi-Parkinson’s Model
por: Chen, Yuan-Hao, et al.
Publicado: (2018)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

The Effects of Inhibition of MicroRNA-375 in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity
por: Zhang, Hao, et al.
Publicado: (2020)

Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson’s Disease
por: Gan, Ping, et al.
Publicado: (2020)

Role of upregulation of the K(ATP) channel subunit SUR1 in dopaminergic neuron degeneration in Parkinson’s disease
por: Liu, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vnnl5smtgun1m08l77vous92ji